Richard Kellermayer, MD, PhD
- Gastroenterology, Hepatology and Nutrition
Director of the Pediatric Inflammatory Bowel Disease Program
Physician
Professor of Pediatrics, Baylor College of Medicine
Phone:
832-822-3131
Languages: English
Office locations:
18200 Katy Fwy
Houston, TX 77094
7900 Fannin, Ste. 3500
Houston, TX 77054
Get to know Richard Kellermayer, MD, PhD
Dr. Kellermayer is the director of the Pediatric Inflammatory Bowel Disease (IBD) Program at Texas Children's Hospital (TCH), Baylor College of Medicine (BCM). He is a devoted pediatric gastroenterologist striving for outstanding patient care with special interest in IBD (including Crohn's disease and ulcerative colitis). Dr. Kellermayer is an expert in Clostridium difficile infection, and is the Medical Director of the Fecal Microbiota Transplantation (FMT) program at TCH. He is a passionate researcher with focus on the microbiome and the environmental (nutritional and epigenetic) origins of IBD. Dr. Kellermayer is also an avid teacher of multiple pre-and postgraduate students, and clinical fellows.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Texas Children's Hospital | Fellowship | Pediatric Gastroenterology | 2008 |
| University Medical School of Pecs | Fellowship | Medical Genetics | 2005 |
| University Medical School of Pecs | Postgraduate Education | Molecular & Human Genetics | 2005 |
| Women and Children's Hospital of Buffalo | Residency | Pediatrics | 2003 |
| University Medical School of Pecs | Medical School | Doctor of Medicine | 1997 |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Reviews
Queliza K, Ihekweazu FD, Ali A, Kellermayer R. Inflammatory Bowel Disease and Immune Thrombocytopenic Purpura: Combined Immune Dysregulation in an Adolescent. Annals of Clinical & Laboraty Science 2017 Mar;47(2):226-228.
Shiau H, Ihekweazu FD, Amin M, Fofanova T, Miloh T, Kellermayer R. The Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single Center Study. Journal of Pediatric Gastroenterology & Nutrition 2017 Jan 28.
Shah R, Cope JL, Nagy-Szakal D, Dowd S, Versalovic J, Hollister EB, Kellermayer R. Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis. Gut Microbes 2016 Sep 2;7(5):384-96.
Harris RA, Shah R, Hollister EB, Tronstad RR, Hovdenak N, Szigeti R, Versalovic J, Kellermayer R. Colonic Mucosal Epigenome and Microbiome Development in Children and Adolescents. Journal of Immunology Research 2016:9170162.
Kugathasan S,…., Kellermayer R, ….., Hyams JS, Dubinsky MC. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet 2017 Apr 29;389(10080):1710-1718.